INSIGHTS ON CLINICAL TRIAL DESIGN
-
Delivering An Early-Phase Autoimmune Trial Across Regions
Why do autoimmune trials stall when patients already have working treatments? See how one rare rheumatology study adapted its strategy to keep early-phase enrollment moving.
-
Site Selection Solutions Using Patient Insights For Rare Disease Trials
Uncover recruitment opportunities and strengthen patient engagement with a data-driven approach to rare disease site selection, enrollment, and retention.
-
Supporting And Enabling High-Performing Clinical Trial Sites
Fragmented travel, payment, and site finance services stall studies. Unifying them creates greater predictability across sponsors, CROs, and sites.
-
Transforming Effective Patient Recruitment Within The Changing Health Care Landscape
Revolutionize patient enrollment by closing the "95% gap." Explore an approach that uses digital health and data-driven insights to engage diverse populations where they live.
-
Taking Research In-House With CRIO: SciTech's Multi-Center Phase 1 Study1/6/2025
Explore the success story of an early-stage clinical pharmaceutical company that effectively navigated funding constraints when conducting its Phase 1 study without a third-party CRO.
-
Executing Concurrent Decentralized RCTs And RWE At Scale3/31/2026
See how a team of four managed data for 40 peer-reviewed studies and 200,000 participants.
-
Completed Clinical Trials Continued To Climb In 20246/19/2025
Data collected in this report reflects a shift toward sustained growth, reflecting rapid advancement in therapeutic areas such as oncology, autoimmune/inflammation, and central nervous system studies.
-
What Can Healthy Participants Tell Us In Early Immuno-oncology Development?10/31/2026
Healthy participants may help answer early immuno-oncology questions when targets, endpoints, and risks align. Human data shows where this approach works and where it doesn’t.
-
Helping Biotechs Overcome 4 Key Challenges3/10/2025
Delays in site payments, participant reimbursements, and logistical inefficiencies can create roadblocks for patients and sites.
CLINICAL TRIAL DESIGN SOLUTIONS
-
While automated inventory management systems play a crucial role in tracking samples, kit availability, and supply levels human involvement is still important to the adaptability of a clinical trial.
-
Psychiatric trials have long been among the most difficult to enroll. From treatment-resistant depression (TRD) and PTSD to cognitive and neuro disorders, sponsors are facing the same challenges over and over again:
- Narrow I/E criteria that don’t translate into real-world patients
- Sites with limited behavioral health infrastructure
- Lack of patient trust and trial awareness in psychiatric populations
- Professional patients
- Rating scales aren’t used in clinical practices
But what if recruitment didn’t have to start with a gamble?
-
Through Home Trial Support (HTS), it is possible to carry out even the most demanding sampling protocols safely, consistently, and at scale—bringing collection and processing directly to patients.
-
Discover how Scout supports patient retention with people-first solutions for reimbursement and travel at no cost to sites.
-
Bridge the gap between raw data and clinical enrollment. Use AI-driven insights and natural language summaries to identify the right patients faster and with greater transparency.